config1.json
... ...
@@ -1,12 +0,0 @@
1
-{
2
- "theme": "base",
3
- "themeVariables": {
4
- "fontSize": "33px"
5
- },
6
- "sankey": {
7
- "height": 1000,
8
- "width": 800,
9
- "showValues": false,
10
- "linkColor": "target"
11
- }
12
-}
config2.json
... ...
@@ -1,12 +0,0 @@
1
-{
2
- "theme": "base",
3
- "themeVariables": {
4
- "fontSize": "33px"
5
- },
6
- "sankey": {
7
- "height": 700,
8
- "width": 800,
9
- "showValues": false,
10
- "linkColor": "target"
11
- }
12
-}
test_with_bib.md
... ...
@@ -1,240 +0,0 @@
1
-| Gene | Reference |
2
-|:---------:|:-----------------------------:|
3
-| ABL2 | (Russler-Germain et al. 2023) |
4
-| HIST1H2BD | (Krysiak et al. 2017) |
5
-| CPNE8 | (Hübschmann et al. 2021) |
6
-| HIST1H2AG | (Krysiak et al. 2017) |
7
-| BIRC6 | |
8
-| CXCR4 | (Krysiak et al. 2017) |
9
-| STAT6 | (Yildiz et al. 2015) |
10
-| CARD11 | (Morin et al. 2011) |
11
-| ITPKB | |
12
-| ACTG1 | (Hübschmann et al. 2021) |
13
-| HIST1H2BC | (Krysiak et al. 2017) |
14
-| POU2AF1 | (Krysiak et al. 2017) |
15
-| SESN1 | |
16
-| CILP | (Russler-Germain et al. 2023) |
17
-| MEF2C | |
18
-| PRKDC | (Hübschmann et al. 2021) |
19
-| TP53 | (Morin et al. 2011) |
20
-| KLF2 | |
21
-| MYCBP2 | (Hübschmann et al. 2021) |
22
-| BCL7A | (Krysiak et al. 2017) |
23
-| B2M | (Morin et al. 2011) |
24
-| VMA21 | (Hübschmann et al. 2021) |
25
-| BCL10 | (Russler-Germain et al. 2023) |
26
-| DUSP2 | |
27
-| MAP2K1 | (Louissaint et al. 2016) |
28
-| IGLL5 | (Russler-Germain et al. 2023) |
29
-| ZC3H12A | |
30
-| JUP | (Hübschmann et al. 2021) |
31
-| TMEM30A | (Morin et al. 2011) |
32
-| ATP6V1B2 | (Okosun et al. 2016) |
33
-| SOCS1 | |
34
-| CYP2A6 | (Russler-Germain et al. 2023) |
35
-| HIST1H3B | |
36
-| SRRM2 | (Russler-Germain et al. 2023) |
37
-| HIST1H3G | (Krysiak et al. 2017) |
38
-| HIST1H2AM | (Krysiak et al. 2017) |
39
-| GNA13 | (Morin et al. 2011) |
40
-| HIST1H1B | (Krysiak et al. 2017) |
41
-| PPP4C | (Hübschmann et al. 2021) |
42
-| MYD88 | |
43
-| PTPRD | |
44
-| EEF1A1 | (Hübschmann et al. 2021) |
45
-| CCND3 | (Morin et al. 2011) |
46
-| LAPTM5 | (Hübschmann et al. 2021) |
47
-| TNFAIP3 | |
48
-| HIST1H1C | (Morin et al. 2011) |
49
-| GBP7 | (Russler-Germain et al. 2023) |
50
-| XIRP2 | (Russler-Germain et al. 2023) |
51
-| GRM6 | (Russler-Germain et al. 2023) |
52
-| CREBBP | (Pasqualucci et al. 2011) |
53
-| SGK1 | (Morin et al. 2011) |
54
-| CD79B | |
55
-| ATP6AP1 | (Okosun et al. 2016) |
56
-| HNRNPD | |
57
-| OR8H2 | (Russler-Germain et al. 2023) |
58
-| IRF8 | (Morin et al. 2011) |
59
-| ZNF608 | (Krysiak et al. 2017) |
60
-| SHROOM3 | (Russler-Germain et al. 2023) |
61
-| HVCN1 | (Krysiak et al. 2017) |
62
-| TBL1XR1 | |
63
-| CD83 | (Russler-Germain et al. 2023) |
64
-| DTX1 | |
65
-| KLHL6 | (Morin et al. 2011) |
66
-| EBF1 | |
67
-| CD70 | (Russler-Germain et al. 2023) |
68
-| IRF4 | |
69
-| STAB2 | (Russler-Germain et al. 2023) |
70
-| TNFRSF14 | (Cheung et al. 2010) |
71
-| FAS | |
72
-| BTK | (Krysiak et al. 2017) |
73
-| FOXO1 | (Morin et al. 2011) |
74
-| SMARCA4 | (Krysiak et al. 2017) |
75
-| POU2F2 | (Krysiak et al. 2017) |
76
-| RRAGC | |
77
-| KIR3DL1 | (Russler-Germain et al. 2023) |
78
-| HIST1H1D | (Krysiak et al. 2017) |
79
-| BCL2 | (Morin et al. 2011) |
80
-| EGR1 | (Krysiak et al. 2017) |
81
-| ACTB | |
82
-| PZP | (Russler-Germain et al. 2023) |
83
-| GNAI2 | |
84
-| DHX15 | (Hübschmann et al. 2021) |
85
-| ATP6V1A | (Hübschmann et al. 2021) |
86
-| PDS5B | (Hübschmann et al. 2021) |
87
-| BCL6 | |
88
-| HIST1H2BM | (Krysiak et al. 2017) |
89
-| PIM1 | |
90
-| MEF2B | (Morin et al. 2011) |
91
-| EZH2 | (Morin et al. 2010) |
92
-| MAGEC1 | (Russler-Germain et al. 2023) |
93
-| KMT2D | (Morin et al. 2011) |
94
-| ARID1A | (Krysiak et al. 2017) |
95
-| MAP7D1 | (Russler-Germain et al. 2023) |
96
-| DDX3X | |
97
-| MGEA5 | (Hübschmann et al. 2021) |
98
-| MKI67 | (Russler-Germain et al. 2023) |
99
-| HIST1H3I | (Krysiak et al. 2017) |
100
-| CCDC42BPB | (Hübschmann et al. 2021) |
101
-| HIST1H1E | (Krysiak et al. 2017) |
102
-| TMSB4X | |
103
-| TPP1 | (Hübschmann et al. 2021) |
104
-| HLA-B | |
105
-| PCLO | |
106
-| FZR1 | (Hübschmann et al. 2021) |
107
-| S1PR2 | |
108
-| BTG1 | |
109
-| BTG2 | (Morin et al. 2011) |
110
-| HIST1H2BG | (Krysiak et al. 2017) |
111
-| LTB | |
112
-| EP300 | (Pasqualucci et al. 2011) |
113
-| CTSS | (Bararia et al. 2020) |
114
-| HIST1H2AC | (Krysiak et al. 2017) |
115
-| NFKBIA | (Russler-Germain et al. 2023) |
116
-| P2RY8 | |
117
-| RBM6 | (Hübschmann et al. 2021) |
118
-| MYC | |
119
-
120
-<div id="refs" class="references csl-bib-body hanging-indent">
121
-
122
-<div id="ref-barariaCathepsinAlterationsInduce2020c" class="csl-entry">
123
-
124
-Bararia, Deepak, Johannes A. Hildebrand, Sebastian Stolz, Sarah Haebe,
125
-Stefan Alig, Christopher P. Trevisani, Francisco Osorio-Barrios, et al.
126
-2020. “Cathepsin S Alterations Induce a Tumor-Promoting Immune
127
-Microenvironment in Follicular Lymphoma.” *Cell Reports* 31 (5): 107522.
128
-<https://doi.org/10.1016/j.celrep.2020.107522>.
129
-
130
-</div>
131
-
132
-<div id="ref-cheungAcquiredTNFRSF14Mutations2010a" class="csl-entry">
133
-
134
-Cheung, K.-John J., Nathalie A. Johnson, Joslynn G. Affleck, Tesa
135
-Severson, Christian Steidl, Susana Ben-Neriah, Jacqueline Schein, et al.
136
-2010. “Acquired TNFRSF14 Mutations in Follicular Lymphoma Are Associated
137
-with Worse Prognosis.” *Cancer Research* 70 (22): 9166–74.
138
-<https://doi.org/10.1158/0008-5472.CAN-10-2460>.
139
-
140
-</div>
141
-
142
-<div id="ref-hubschmannMutationalMechanismsShaping2021b"
143
-class="csl-entry">
144
-
145
-Hübschmann, Daniel, Kortine Kleinheinz, Rabea Wagener, Stephan H.
146
-Bernhart, Cristina López, Umut H. Toprak, Stephanie Sungalee, et al.
147
-2021. “Mutational Mechanisms Shaping the Coding and Noncoding Genome of
148
-Germinal Center Derived <span class="nocase">B-cell</span> Lymphomas.”
149
-*Leukemia* 35 (7): 2002–16.
150
-<https://doi.org/10.1038/s41375-021-01251-z>.
151
-
152
-</div>
153
-
154
-<div id="ref-krysiakRecurrentSomaticMutations2017b" class="csl-entry">
155
-
156
-Krysiak, Kilannin, Felicia Gomez, Brian S. White, Matthew Matlock,
157
-Christopher A. Miller, Lee Trani, Catrina C. Fronick, et al. 2017.
158
-“Recurrent Somatic Mutations Affecting <span
159
-class="nocase">B-cell</span> Receptor Signaling Pathway Genes in
160
-Follicular Lymphoma.” *Blood* 129 (4): 473–83.
161
-<https://doi.org/10.1182/blood-2016-07-729954>.
162
-
163
-</div>
164
-
165
-<div id="ref-louissaintPediatrictypeNodalFollicular2016a"
166
-class="csl-entry">
167
-
168
-Louissaint, Abner, Kristian T. Schafernak, Julia T. Geyer, Alexandra E.
169
-Kovach, Mahmoud Ghandi, Dita Gratzinger, Christine G. Roth, et al. 2016.
170
-“Pediatric-Type Nodal Follicular Lymphoma: A Biologically Distinct
171
-Lymphoma with Frequent MAPK Pathway Mutations.” *Blood* 128 (8):
172
-1093–1100. <https://doi.org/10.1182/blood-2015-12-682591>.
173
-
174
-</div>
175
-
176
-<div id="ref-morinSomaticMutationsAltering2010a" class="csl-entry">
177
-
178
-Morin, Ryan D., Nathalie A. Johnson, Tesa M. Severson, Andrew J.
179
-Mungall, Jianghong An, Rodrigo Goya, Jessica E. Paul, et al. 2010.
180
-“Somatic Mutations Altering EZH2 (Tyr641) in Follicular and Diffuse
181
-Large <span class="nocase">B-cell</span> Lymphomas of Germinal-Center
182
-Origin.” *Nature Genetics* 42 (2): 181–85.
183
-<https://doi.org/10.1038/ng.518>.
184
-
185
-</div>
186
-
187
-<div id="ref-morinFrequentMutationHistonemodifying2011"
188
-class="csl-entry">
189
-
190
-Morin, Ryan D., Maria Mendez-Lago, Andrew J. Mungall, Rodrigo Goya,
191
-Karen L. Mungall, Richard D. Corbett, Nathalie A. Johnson, et al. 2011.
192
-“Frequent Mutation of Histone-Modifying Genes in Non-Hodgkin Lymphoma.”
193
-*Nature* 476 (7360): 298–303. <https://doi.org/10.1038/nature10351>.
194
-
195
-</div>
196
-
197
-<div id="ref-okosunRecurrentMTORC1activatingRRAGC2016a"
198
-class="csl-entry">
199
-
200
-Okosun, Jessica, Rachel L. Wolfson, Jun Wang, Shamzah Araf, Lucy
201
-Wilkins, Brian M. Castellano, Leire Escudero-Ibarz, et al. 2016.
202
-“Recurrent <span class="nocase">mTORC1-activating RRAGC</span> Mutations
203
-in Follicular Lymphoma.” *Nature Genetics* 48 (2): 183–88.
204
-<https://doi.org/10.1038/ng.3473>.
205
-
206
-</div>
207
-
208
-<div id="ref-pasqualucciInactivatingMutationsAcetyltransferase2011a"
209
-class="csl-entry">
210
-
211
-Pasqualucci, Laura, David Dominguez-Sola, Annalisa Chiarenza, Giulia
212
-Fabbri, Adina Grunn, Vladimir Trifonov, Lawryn H. Kasper, et al. 2011.
213
-“Inactivating Mutations of Acetyltransferase Genes in <span
214
-class="nocase">B-cell</span> Lymphoma.” *Nature* 471 (7337): 189–95.
215
-<https://doi.org/10.1038/nature09730>.
216
-
217
-</div>
218
-
219
-<div id="ref-russler-germainMutationsAssociatedProgression2023b"
220
-class="csl-entry">
221
-
222
-Russler-Germain, David A., Kilannin Krysiak, Cody A. Ramirez, Matthew
223
-Mosior, Marcus P. Watkins, Felicia Gomez, Zachary L. Skidmore, et al.
224
-2023. “Mutations Associated with Progression in Follicular Lymphoma
225
-Predict Inferior Outcomes at Diagnosis: Alliance A151303.” *Blood
226
-Advances* 7: 5524–39.
227
-<https://doi.org/10.1182/bloodadvances.2023010779>.
228
-
229
-</div>
230
-
231
-<div id="ref-yildizActivatingSTAT6Mutations2015c" class="csl-entry">
232
-
233
-Yildiz, Mehmet, Hongxiu Li, Denzil Bernard, Nisar A. Amin, Peter
234
-Ouillette, Siân Jones, Kamlai Saiya-Cork, et al. 2015. “Activating STAT6
235
-Mutations in Follicular Lymphoma.” *Blood* 125 (4): 668–79.
236
-<https://doi.org/10.1182/blood-2014-06-582650>.
237
-
238
-</div>
239
-
240
-</div>
tier1_pmbl_hl_gz.md
... ...
@@ -1,76 +0,0 @@
1
-| Category | Gene | Details | Mutation frequency | Static view (Gene) | Static view (Protein) | Comment |
2
-| :---: | :----: | :---: | :---: | :---: |
3
-|:--:|[ACTB](ACTB)|:-:|:-:|
4
-|1|[ARID1A](ARID1A)||[view](images/proteinpaint/ARID1A.svg)|[view](images/proteinpaint/ARID1A_NM_006015.svg)|
5
-|1|[ARID5B](ARID5B)||[view](images/proteinpaint/ARID5B.svg)|[view](images/proteinpaint/ARID5B_NM_032199.svg)|
6
-|1|[B2M](B2M)||[view](images/proteinpaint/B2M.svg)|[view](images/proteinpaint/B2M_NM_004048.svg)|
7
-|1|[BIRC6](BIRC6)||[view](images/proteinpaint/BIRC6.svg)|[view](images/proteinpaint/BIRC6_NM_016252.svg)|
8
-|1-a|[BTG1](BTG1)||[view](images/proteinpaint/BTG1.svg)|[view](images/proteinpaint/BTG1_NM_001731.svg)|
9
-|1|[CARD11](CARD11)||[view](images/proteinpaint/CARD11.svg)|[view](images/proteinpaint/CARD11_NM_032415.svg)|
10
-|1|[CD58](CD58)||[view](images/proteinpaint/CD58.svg)|[view](images/proteinpaint/CD58_NM_001779.svg)|
11
-|1-a|[CD83](CD83)||[view](images/proteinpaint/CD83.svg)|[view](images/proteinpaint/CD83_NM_004233.svg)|
12
-|1|[CDKN2A](CDKN2A)||[view](images/proteinpaint/CDKN2A.svg)|[view](images/proteinpaint/CDKN2A_NM_000077.svg)|
13
-|1|[CHD8](CHD8)||[view](images/proteinpaint/CHD8.svg)|[view](images/proteinpaint/CHD8_NM_001170629.svg)|
14
-|1|[CREBBP](CREBBP)||[view](images/proteinpaint/CREBBP.svg)|[view](images/proteinpaint/CREBBP_NM_004380.svg)|
15
-|1|[CSF2RB](CSF2RB)||[LOAD](https://morinlab.github.io/LLMPP/GAMBL/CSF2RB.html)|[LOAD](https://morinlab.github.io/LLMPP/GAMBL/CSF2RB_protein.html)|
16
-|1|[DDX3X](DDX3X)||[view](images/proteinpaint/DDX3X.svg)|[view](images/proteinpaint/DDX3X_NM_001356.svg)|
17
-|1-a|[DTX1](DTX1)||[view](images/proteinpaint/DTX1.svg)|[view](images/proteinpaint/DTX1_NM_004416.svg)|
18
-|1-a|[DUSP2](DUSP2)||[view](images/proteinpaint/DUSP2.svg)|[view](images/proteinpaint/DUSP2_NM_004418.svg)|
19
-|1-a|[EBF1](EBF1)||[view](images/proteinpaint/EBF1.svg)|[view](images/proteinpaint/EBF1_NM_024007.svg)|
20
-|1|[EP300](EP300)||[view](images/proteinpaint/EP300.svg)|[view](images/proteinpaint/EP300_NM_001429.svg)|
21
-|1-a|[ETS1](ETS1)||[view](images/proteinpaint/ETS1.svg)|[view](images/proteinpaint/ETS1_NM_001143820.svg)|
22
-|1|[EWSR1](EWSR1)||[view](images/proteinpaint/EWSR1.svg)|[view](images/proteinpaint/EWSR1_NM_013986.svg)|
23
-|1|[EZH2](EZH2)||[view](images/proteinpaint/EZH2.svg)|[view](images/proteinpaint/EZH2_NM_001203247.svg)|
24
-|1|[FAS](FAS)||[view](images/proteinpaint/FAS.svg)|[view](images/proteinpaint/FAS_NM_000043.svg)|
25
-|1|[FAT1](FAT1)||[LOAD](https://morinlab.github.io/LLMPP/GAMBL/FAT1.html)|[LOAD](https://morinlab.github.io/LLMPP/GAMBL/FAT1_protein.html)|
26
-|1|[FAT4](FAT4)||[view](images/proteinpaint/FAT4.svg)|[view](images/proteinpaint/FAT4_NM_024582.svg)|
27
-|1|[GNA13](GNA13)||[view](images/proteinpaint/GNA13.svg)|[view](images/proteinpaint/GNA13_NM_006572.svg)|
28
-|1|[H1-2](H1-2)(HIST1H1C)||[LOAD](https://morinlab.github.io/LLMPP/GAMBL/H1-2.html)|[view](images/proteinpaint/HIST1H1C_NM_005319.svg)|
29
-|1|[H1-3](H1-3)(HIST1H1D)||[LOAD](https://morinlab.github.io/LLMPP/GAMBL/H1-3.html)|[view](images/proteinpaint/HIST1H1D_NM_005320.svg)|
30
-|1|[H1-4](H1-4)(HIST1H1E)||[LOAD](https://morinlab.github.io/LLMPP/GAMBL/H1-4.html)|[view](images/proteinpaint/HIST1H1E_NM_005321.svg)|
31
-|1|[H1-5](H1-5)(HIST1H1B)||[LOAD](https://morinlab.github.io/LLMPP/GAMBL/H1-5.html)|[view](images/proteinpaint/HIST1H1B_NM_005322.svg)|
32
-|1|[HLA-B](HLA-B)||[view](images/proteinpaint/HLA-B.svg)|[view](images/proteinpaint/HLA-B_NM_005514.svg)|
33
-|1-a|[IL4R](IL4R)||[view](images/proteinpaint/IL4R.svg)|[view](images/proteinpaint/IL4R_NM_000418.svg)|
34
-|1-a|[IRF8](IRF8)||[view](images/proteinpaint/IRF8.svg)|[view](images/proteinpaint/IRF8_NM_002163.svg)|
35
-|1-a|[ITPKB](ITPKB)||[view](images/proteinpaint/ITPKB.svg)|[view](images/proteinpaint/ITPKB_NM_002221.svg)|
36
-|1|[JAK1](JAK1)||[view](images/proteinpaint/JAK1.svg)|[view](images/proteinpaint/JAK1_NM_002227.svg)|
37
-|1|[KMT2C](KMT2C)||[view](images/proteinpaint/KMT2C.svg)|[view](images/proteinpaint/KMT2C_NM_170606.svg)|
38
-|1-a|[LTB](LTB)||[view](images/proteinpaint/LTB.svg)|[view](images/proteinpaint/LTB_NM_002341.svg)|
39
-|1-a|[MS4A1](MS4A1)||[view](images/proteinpaint/MS4A1.svg)|[LOAD](https://morinlab.github.io/LLMPP/GAMBL/MS4A1_protein.html)|
40
-|1|[NFKBIA](NFKBIA)||[view](images/proteinpaint/NFKBIA.svg)|[view](images/proteinpaint/NFKBIA_NM_020529.svg)|
41
-|1|[NFKBIE](NFKBIE)||[view](images/proteinpaint/NFKBIE.svg)|[view](images/proteinpaint/NFKBIE_NM_004556.svg)|
42
-|1-a|[OSBPL10](OSBPL10)||[view](images/proteinpaint/OSBPL10.svg)|[view](images/proteinpaint/OSBPL10_NM_017784.svg)|
43
-|1|[P2RY8](P2RY8)||[view](images/proteinpaint/P2RY8.svg)|[view](images/proteinpaint/P2RY8_NM_178129.svg)|
44
-|1|[PCLO](PCLO)||[view](images/proteinpaint/PCLO.svg)|[view](images/proteinpaint/PCLO_NM_033026.svg)|
45
-|1|[PHIP](PHIP)||[LOAD](https://morinlab.github.io/LLMPP/GAMBL/PHIP.html)|[LOAD](https://morinlab.github.io/LLMPP/GAMBL/PHIP_protein.html)|
46
-|1-a|[PIM1](PIM1)||[view](images/proteinpaint/PIM1.svg)|[view](images/proteinpaint/PIM1_NM_002648.svg)|
47
-|1-a|[PIM2](PIM2)||[view](images/proteinpaint/PIM2.svg)|[view](images/proteinpaint/PIM2_NM_006875.svg)|
48
-|1|[PRKDC](PRKDC)||[view](images/proteinpaint/PRKDC.svg)|[view](images/proteinpaint/PRKDC_NM_006904.svg)|
49
-|1-a|[PTPN1](PTPN1)||[view](images/proteinpaint/PTPN1.svg)|[view](images/proteinpaint/PTPN1_NM_002827.svg)|
50
-|1|[PTPRD](PTPRD)||[view](images/proteinpaint/PTPRD.svg)|[view](images/proteinpaint/PTPRD_NM_002839.svg)|
51
-|1|[RHOA](RHOA)||[view](images/proteinpaint/RHOA.svg)|[view](images/proteinpaint/RHOA_NM_001664.svg)|
52
-|1-a|[S1PR2](S1PR2)||[view](images/proteinpaint/S1PR2.svg)|[view](images/proteinpaint/S1PR2_NM_004230.svg)|
53
-|1-a|[SGK1](SGK1)||[view](images/proteinpaint/SGK1.svg)|[view](images/proteinpaint/SGK1_NM_005627.svg)|
54
-|1|[SIN3A](SIN3A)||[view](images/proteinpaint/SIN3A.svg)|[view](images/proteinpaint/SIN3A_NM_001145358.svg)|
55
-|1|[SMARCA2](SMARCA2)||[LOAD](https://morinlab.github.io/LLMPP/GAMBL/SMARCA2.html)|[LOAD](https://morinlab.github.io/LLMPP/GAMBL/SMARCA2_protein.html)|
56
-|1|[SMARCA4](SMARCA4)||[view](images/proteinpaint/SMARCA4.svg)|[view](images/proteinpaint/SMARCA4_NM_001128849.svg)|
57
-|1-a|[SOCS1](SOCS1)||[view](images/proteinpaint/SOCS1.svg)|[view](images/proteinpaint/SOCS1_NM_003745.svg)|
58
-|1|[SPEN](SPEN)||[view](images/proteinpaint/SPEN.svg)|[view](images/proteinpaint/SPEN_NM_015001.svg)|
59
-|1|[STAT3](STAT3)||[view](images/proteinpaint/STAT3.svg)|[view](images/proteinpaint/STAT3_NM_139276.svg)|
60
-|1|[STAT6](STAT6)||[view](images/proteinpaint/STAT6.svg)|[view](images/proteinpaint/STAT6_NM_003153.svg)|
61
-|1|[TAP1](TAP1)||[view](images/proteinpaint/TAP1.svg)|[view](images/proteinpaint/TAP1_NM_000593.svg)|
62
-|1|[TBL1XR1](TBL1XR1)||[view](images/proteinpaint/TBL1XR1.svg)|[view](images/proteinpaint/TBL1XR1_NM_024665.svg)|
63
-|1|[TCF3](TCF3)||[view](images/proteinpaint/TCF3.svg)|[view](images/proteinpaint/TCF3_NM_003200.svg)|
64
-|1|[TET3](TET3)||[LOAD](https://morinlab.github.io/LLMPP/GAMBL/TET3.html)|[LOAD](https://morinlab.github.io/LLMPP/GAMBL/TET3_protein.html)|
65
-|1-a|[TMSB4X](TMSB4X)||[view](images/proteinpaint/TMSB4X.svg)|[view](images/proteinpaint/TMSB4X_NM_021109.svg)|
66
-|1|[TNFAIP3](TNFAIP3)||[view](images/proteinpaint/TNFAIP3.svg)|[view](images/proteinpaint/TNFAIP3_NM_006290.svg)|
67
-|1|[TNFRSF1B](TNFRSF1B)||[LOAD](https://morinlab.github.io/LLMPP/GAMBL/TNFRSF1B.html)|[LOAD](https://morinlab.github.io/LLMPP/GAMBL/TNFRSF1B_protein.html)|
68
-|1|[TP53](TP53)||[view](images/proteinpaint/TP53.svg)|[view](images/proteinpaint/TP53_NM_000546.svg)|
69
-|1|[TRAF3](TRAF3)||[view](images/proteinpaint/TRAF3.svg)|[view](images/proteinpaint/TRAF3_NM_145725.svg)|
70
-|1|[UBE2A](UBE2A)||[view](images/proteinpaint/UBE2A.svg)|[view](images/proteinpaint/UBE2A_NM_003336.svg)|
71
-|1|[UBR5](UBR5)||[view](images/proteinpaint/UBR5.svg)|[view](images/proteinpaint/UBR5_NM_015902.svg)|
72
-|1|[UNC5C](UNC5C)||[view](images/proteinpaint/UNC5C.svg)|[view](images/proteinpaint/UNC5C_NM_003728.svg)|
73
-|1|[VPS13B](VPS13B)||[view](images/proteinpaint/VPS13B.svg)|[view](images/proteinpaint/VPS13B_NM_152564.svg)|
74
-|1-a|[WEE1](WEE1)||[view](images/proteinpaint/WEE1.svg)|[view](images/proteinpaint/WEE1_NM_003390.svg)|
75
-|1|[XPO1](XPO1)||[view](images/proteinpaint/XPO1.svg)|[view](images/proteinpaint/XPO1_NM_003400.svg)|
76
-|1-a|[ZFP36L1](ZFP36L1)||[view](images/proteinpaint/ZFP36L1.svg)|[view](images/proteinpaint/ZFP36L1_NM_004926.svg)|
tier2_pmbl_hl_gz.md
... ...
@@ -1,35 +0,0 @@
1
-| Category | Gene | Details | Mutation frequency | Static view (Gene) | Static view (Protein) | Comment |
2
-| :---: | :----: | :---: | :---: | :---: |
3
-|:--:|[ACTG1](ACTG1)|:-:|:-:|
4
-|2|[ADGRG6](ADGRG6)||[LOAD](https://morinlab.github.io/LLMPP/GAMBL/ADGRG6.html)|[LOAD](https://morinlab.github.io/LLMPP/GAMBL/ADGRG6_protein.html)|
5
-|2|[AXDND1](AXDND1)||[LOAD](https://morinlab.github.io/LLMPP/GAMBL/AXDND1.html)|[LOAD](https://morinlab.github.io/LLMPP/GAMBL/AXDND1_protein.html)|
6
-|2-a|[BCL7A](BCL7A)||[view](images/proteinpaint/BCL7A.svg)|[view](images/proteinpaint/BCL7A_NM_020993.svg)|
7
-|2|[CCND3](CCND3)||[view](images/proteinpaint/CCND3.svg)|[view](images/proteinpaint/CCND3_NM_001760.svg)|
8
-|2|[CDH5](CDH5)||[LOAD](https://morinlab.github.io/LLMPP/GAMBL/CDH5.html)|[LOAD](https://morinlab.github.io/LLMPP/GAMBL/CDH5_protein.html)|
9
-|2|[CHD2](CHD2)||[LOAD](https://morinlab.github.io/LLMPP/GAMBL/CHD2.html)|[LOAD](https://morinlab.github.io/LLMPP/GAMBL/CHD2_protein.html)|
10
-|2-a|[CIITA](CIITA)||[view](images/proteinpaint/CIITA.svg)|[view](images/proteinpaint/CIITA_NM_000246.svg)|
11
-|2|[CISH](CISH)||[LOAD](https://morinlab.github.io/LLMPP/GAMBL/CISH.html)|[LOAD](https://morinlab.github.io/LLMPP/GAMBL/CISH_protein.html)|
12
-|2|[DNAH12](DNAH12)||[LOAD](https://morinlab.github.io/LLMPP/GAMBL/DNAH12.html)|[LOAD](https://morinlab.github.io/LLMPP/GAMBL/DNAH12_protein.html)|
13
-|2|[EEF1A1](EEF1A1)||[view](images/proteinpaint/EEF1A1.svg)|[view](images/proteinpaint/EEF1A1_NM_001402.svg)|
14
-|2|[EGR1](EGR1)||[LOAD](https://morinlab.github.io/LLMPP/GAMBL/EGR1.html)|[LOAD](https://morinlab.github.io/LLMPP/GAMBL/EGR1_protein.html)|
15
-|2|[HLA-A](HLA-A)||[view](images/proteinpaint/HLA-A.svg)|[view](images/proteinpaint/HLA-A_NM_002116.svg)|
16
-|2|[HLA-C](HLA-C)||[view](images/proteinpaint/HLA-C.svg)|[view](images/proteinpaint/HLA-C_NM_002117.svg)|
17
-|2-a|[IGLL5](IGLL5)||[view](images/proteinpaint/IGLL5.svg)|[view](images/proteinpaint/IGLL5_NM_001178126.svg)|
18
-|2-a|[IRF4](IRF4)||[view](images/proteinpaint/IRF4.svg)|[view](images/proteinpaint/IRF4_NM_002460.svg)|
19
-|2|[IKBKB](IKBKB)||[view](images/proteinpaint/IKBKB.svg)|[view](images/proteinpaint/IKBKB_NM_001556.svg)|
20
-|2|[ITGB2](ITGB2)||[LOAD](https://morinlab.github.io/LLMPP/GAMBL/ITGB2.html)|[LOAD](https://morinlab.github.io/LLMPP/GAMBL/ITGB2_protein.html)|
21
-|2-a|[KLF2](KLF2)||[view](images/proteinpaint/KLF2.svg)|[view](images/proteinpaint/KLF2_NM_016270.svg)|
22
-|2|[KMT2D](KMT2D)||[view](images/proteinpaint/KMT2D.svg)|[view](images/proteinpaint/KMT2D_NM_003482.svg)|
23
-|2|[LIMD2](LIMD2)||[LOAD](https://morinlab.github.io/LLMPP/GAMBL/LIMD2.html)|[LOAD](https://morinlab.github.io/LLMPP/GAMBL/LIMD2_protein.html)|
24
-|2|[MYB](MYB)||[view](images/proteinpaint/MYB.svg)|[view](images/proteinpaint/MYB_NM_001130173.svg)|
25
-|2|[NFKB2](NFKB2)||[view](images/proteinpaint/NFKB2.svg)|[view](images/proteinpaint/NFKB2_NM_001077494.svg)|
26
-|2|[NSD2](NSD2)||[view](images/proteinpaint/NSD2.svg)|[view](images/proteinpaint/NSD2_NM_133330.svg)|
27
-|2|[OR13C2](OR13C2)||[LOAD](https://morinlab.github.io/LLMPP/GAMBL/OR13C2.html)|[LOAD](https://morinlab.github.io/LLMPP/GAMBL/OR13C2_protein.html)|
28
-|2|[PCDH7](PCDH7)||[LOAD](https://morinlab.github.io/LLMPP/GAMBL/PCDH7.html)|[LOAD](https://morinlab.github.io/LLMPP/GAMBL/PCDH7_protein.html)|
29
-|2|[PCBP1](PCBP1)||[view](images/proteinpaint/PCBP1.svg)|[view](images/proteinpaint/PCBP1_NM_006196.svg)|
30
-|2|[RDH12](RDH12)||[LOAD](https://morinlab.github.io/LLMPP/GAMBL/RDH12.html)|[LOAD](https://morinlab.github.io/LLMPP/GAMBL/RDH12_protein.html)|
31
-|2|[RBM38](RBM38)||[LOAD](https://morinlab.github.io/LLMPP/GAMBL/RBM38.html)|[LOAD](https://morinlab.github.io/LLMPP/GAMBL/RBM38_protein.html)|
32
-|2|[SCN9A](SCN9A)||[LOAD](https://morinlab.github.io/LLMPP/GAMBL/SCN9A.html)|[LOAD](https://morinlab.github.io/LLMPP/GAMBL/SCN9A_protein.html)|
33
-|2|[SMAD3](SMAD3)||[LOAD](https://morinlab.github.io/LLMPP/GAMBL/SMAD3.html)|[LOAD](https://morinlab.github.io/LLMPP/GAMBL/SMAD3_protein.html)|
34
-|2|[STRAP](STRAP)||[LOAD](https://morinlab.github.io/LLMPP/GAMBL/STRAP.html)|[LOAD](https://morinlab.github.io/LLMPP/GAMBL/STRAP_protein.html)|
35
-|2|[ZNF217](ZNF217)||[view](images/proteinpaint/ZNF217.svg)|[view](images/proteinpaint/ZNF217_NM_006526.svg)|